Literature DB >> 21830417

A randomized controlled trial comparing fibrin glue and PlasmaJet on the raw surface of the liver after hepatic resection.

Jean Gugenheim1, Luis César Bredt, Antonio Iannelli.   

Abstract

BACKGROUND/AIMS: In order to reduce the rate of bleeding and bile leakage after hepatic resection, different operative techniques have been used such as selective suture, electrocautery, topical hemostatic agents, argon beam coagulation, omentoplasty and application of fibrin glue.
METHODOLOGY: The PlasmaJet, a recent tool that provides a high energy flow of ionized gas which seals small blood and lymph vessels has been recently introduced into clinical practice. We have conducted a randomized trial comparing the application of 5mL of fibrin glue (Tissucol) and the treatment by PlasmaJet (Plasma Surgical Limited, Theale, UK) on the raw surface of the liver stump after elective hepatic resection.
RESULTS: Fifty-eight consecutive hepatic resections were performed and the postoperative mortality, blood transfusions and reoperations were not statistically different between the groups. However, there was a significant reduction of the incidence of collections requiring percutaneous drainage in the PlasmaJet group (p<0.001).
CONCLUSIONS: Compared to fibrin glue application, the employment of PlasmaJet on the raw surface of the liver stump led to a significant reduction of postoperative complications requiring percutaneous drainage after elective hepatectomy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21830417

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  8 in total

Review 1.  Methods to decrease blood loss during liver resection: a network meta-analysis.

Authors:  Elisabetta Moggia; Benjamin Rouse; Constantinos Simillis; Tianjing Li; Jessica Vaughan; Brian R Davidson; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2016-10-31

2.  Video-assisted thoracoscopic PlasmaJet ablation for malignant pleural mesothelioma.

Authors:  Periklis Perikleous; Nizar Asadi; Vladimir Anikin
Journal:  J Vis Surg       Date:  2018-03-20

3.  Anatomic hepatectomy as a definitive treatment for hepatolithiasis: a cohort study.

Authors:  Nicolás Jarufe; Eduardo Figueroa; César Muñoz; Fabrizio Moisan; Julian Varas; José R Valbuena; Claudia Bambs; Jorge Martínez; Fernando Pimentel
Journal:  HPB (Oxford)       Date:  2012-05-28       Impact factor: 3.647

Review 4.  Systematic review and meta-analysis of haemostatic and biliostatic efficacy of fibrin sealants in elective liver surgery.

Authors:  Pandanaboyana Sanjay; David G Watt; Stephen J Wigmore
Journal:  J Gastrointest Surg       Date:  2012-10-20       Impact factor: 3.452

5.  Sustained-released mixture of vascular endothelial growth factor 165 and fibrin glue strengthens healing of ileal anastomoses in a rabbit model with intraperitoneal infection.

Authors:  Zhanwu Li; Wenjun Wang; Xiaozhou Wang; Lei Jiang; Fengyi Wang; Qiang Liu
Journal:  Ann Surg Treat Res       Date:  2017-08-30       Impact factor: 1.859

6.  Randomized controlled multicenter trial on the effectiveness of the collagen hemostat Sangustop® compared with a carrier-bound fibrin sealant during liver resection (ESSCALIVER study, NCT00918619).

Authors:  C Moench; A L Mihaljevic; V Hermanutz; W E Thasler; K Suna; M K Diener; D Seehofer; H J Mischinger; B Jansen-Winkeln; H P Knaebel; W O Bechstein
Journal:  Langenbecks Arch Surg       Date:  2014-06-01       Impact factor: 3.445

7.  Hepatocellular carcinoma: preclinical data on a dual-lumen catheter kit for fibrin sealant infusion following loco-regional treatments.

Authors:  Francesco Izzo; Vittorio Albino; Raffaele Palaia; Mauro Piccirillo; Fabiana Tatangelo; Vincenza Granata; Antonella Petrillo; Secondo Lastoria
Journal:  Infect Agent Cancer       Date:  2014-11-24       Impact factor: 2.965

8.  Organ repair, hemostasis, and in vivo bonding of medical devices by aqueous solutions of nanoparticles.

Authors:  Anne Meddahi-Pellé; Aurélie Legrand; Alba Marcellan; Liliane Louedec; Didier Letourneur; Ludwik Leibler
Journal:  Angew Chem Int Ed Engl       Date:  2014-04-16       Impact factor: 15.336

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.